Debra Hussain new CCO of Acacia Pharma

pharmafile | June 2, 2021 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing  

Acacia Pharma has appointed Debra Hussain as Chief Commercial Officer.

She is a highly experienced commercial leader having spent over 20 years at Eli Lilly in a range of roles.

CEO Mike Bolinder said: “I am so very pleased that we have been able to attract someone of her calibre and experience to join our executive team to fill the role I vacated almost two years ago when I assumed my current role as CEO.

“Deb brings exceptional commercial experience that we believe will complement our current activities, improve our organisational capabilities, and help us to maximise and grow the significant commercial opportunity before us, as we enter the next phase of accelerating our commercial growth, both in the US and internationally.”

Related Content

No items found

Latest content